Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Área temáticas
Fisiología humana(4)
Enfermedades(2)
Farmacología y terapéutica(2)
Anatomía humana, citología, histología(1)
Origen
scopus(4)
Activation of α<inf>1A</inf>-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing
ArticleAbstract: Background and Purpose: A NO-mediated desensitization of vasoconstrictor responses evoked by stimulaPalabras claves:Autores:Agüero J., Almenar L., Arce C., D'Ocon P., Elisabet Vila, Flacco N., Ivorra M.D., Jiménez-Altayó F., Montó F., Noguera M.A., Rueda J., Segura V., Vicente D.Fuentes:scopusDifferent β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: Implications in the relaxant response of rat conductance and resistance vessels
ArticleAbstract: Background and Purpose To analyse the relative contribution of β1-, β2- and β3-adrenoceptors (Adrb)Palabras claves:Aorta, camp, cGMP, mesenteric resistance arteries, mRNA, β-adrenoceptor subtypesAutores:D'Ocon P., Elisabet Vila, Estrada S., Flacco N., Ivorra M.D., Jiménez-Altayó F., Noguera M.A., Perez-Aso M., Segura V., Seller J.F.Fuentes:scopusIncreased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion
ArticleAbstract: BACKGROUND AND PURPOSE Endothelin-1 (ET-1) plays an important role in the maintenance of vascular toPalabras claves:Endothelin-1, ET receptor A, ET receptor B, Ischaemia-reperfusion, mesenteric resistance arteriesAutores:Caracuel L., D'Ocon P., Dantas A.P., Elisabet Vila, Márquez-Martín A., Martínez-Revelles S., Oliver E.Fuentes:scopusMechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines
ArticleAbstract: The activity of (±)‐laudanosine, a benzyltetrahydroisoquinoline alkaloid, was investigated in pithedPalabras claves:benzyltetrahydroisoquinolines, Calcium antagonists, phosphodiesterase inhibitors, Pithed rat, Rat aorta, α ‐adrenoceptors blocking agents 1Autores:Chuliá S., D'Ocon P., Elisabet Vila, Ivorra M.D., Lugnier C., Noguera M.A.Fuentes:scopus